Finance

Lists
RCE:ASX
Recce Pharmaceuticals Ltd
A$0.37
+2.78%
(+0.0100) 1D
Sep 4, 4:10:25 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RCE...
Open
A$0.36
High
A$0.37
Low
A$0.36
Mkt. cap
113.13M
Avg. vol.
63.03K
Volume
75.88K
52-wk high
A$0.73
52-wk low
A$0.35
EPS
-A$0.11
Shares outstanding
305.77M
Open
A$0.36
High
A$0.37
Low
A$0.36
Mkt. cap
113.13M
Avg. vol.
63.03K
Volume
75.88K
52-wk high
A$0.73
52-wk low
A$0.35
EPS
-A$0.11
Shares outstanding
305.77M
About Recce Pharmaceuticals Ltd
CEOJames Graham
Employees-
FoundedApr 11, 2007
Headquarters-
SectorPharmaceutical industry
Websiterecce.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
206.02K
206.02K
4.76M
4.76M
Cost of goods sold
5.05M
5.05M
-973.86K
-973.86K
Cost of revenue
5.05M
5.05M
-973.86K
-973.86K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.39M
2.39M
1.65M
1.65M
Operating expense
3.01M
3.01M
4.53M
4.53M
Total operating expenses
8.06M
8.06M
3.56M
3.56M
Operating income
-7.86M
-7.86M
1.21M
1.21M
Other non operating income
-
-
-
-
EBT including unusual items
-8.28M
-8.28M
799.15K
799.15K
EBT excluding unusual items
-8.28M
-8.28M
799.15K
799.15K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
207.15K
207.15K
2.58M
2.58M
Net income
-8.28M
-8.28M
799.15K
799.15K
Net profit margin
-4,018.96%
-4,018.96%
16.78%
16.78%
Earnings per share
-
-
-
-
Interest and investment income
20.36K
20.36K
-
-
Interest expense
-443.69K
-443.69K
-406.04K
-406.04K
Net interest expenses
-423.33K
-423.33K
-406.04K
-406.04K
Depreciation and amortization charges
33.52K
33.52K
144.68K
144.68K
EBITDA
-7.82M
-7.82M
1.21M
1.21M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps